Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04557423 · ClinicalTrials.gov registry record · NA
Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
A NA study of Uterine Cervical Neoplasms, sponsored by Fox Chase Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 797
- Enrollment target
- 1
- Study location
NCT04557423: Active NA study of Uterine Cervical Neoplasms, sponsored by Fox Chase Cancer Center.
NCT04557423 is a NA study of Uterine Cervical Neoplasms that is active but no longer recruiting, run by Fox Chase Cancer Center. The registered enrollment target is 797 participants, below the 5,454-participant average among 8 other Uterine Cervical Neoplasms trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04557423, a NA study of Uterine Cervical Neoplasms, is active but no longer recruiting, sponsored by Fox Chase Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 797 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized trial to evaluate the effects of a community-based intervention on increasing cervical cancer screening rates in underserved Asian American (Korean, Vietnamese, and Chinese) women. All women will receive an educational program and navigation assistance. Women in the intervention condition will also receive a self-sampling kit for self-collection of a cervical sample for HPV testing. The investigators will evaluate whether the inclusion of a self-sampling kit increases the proportion of Asian American women who participate in cervical cancer screening.
Primary Outcome
The number of women who obtain clinic-based screening or return a self-collected sample
Conditions Studied
Interventions
- BEHAVIORAL Community-Based Education
- BEHAVIORAL Navigation to Screening
- BEHAVIORAL HPV Self-Sampling
Study Locations (1)
Pennsylvania
- Temple University Lewis Katz School of Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 797 participants |
| Start Date | 2021-04-08 |
| Est. Completion | 2025-11-30 |
| Phase | NA |
What the registry record for NCT04557423 still lists
NCT04557423 is an interventional study that assigns participants to a tested intervention. The registered 797 participants enrollment target is mid-sized for trials with a published cap, below the 5,454-participant average among 8 other Uterine Cervical Neoplasms trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Uterine Cervical Neoplasms appearing as the primary indexed condition, and to 3 interventions - of which Community-Based Education is the first listed.
NCT04557423 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04557423 about?
NCT04557423 is a clinical study titled "Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening". This is a randomized trial to evaluate the effects of a community-based intervention on increasing cervical cancer screening rates in underserved Asian American (Korean, Vietnamese, and Chinese) women. All women will receive an educational program and navigation assistance. Women in the intervention...
What is the current status of trial NCT04557423?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 797 participants. The study started on 2021-04-08. Estimated completion is 2025-11-30.
What conditions does trial NCT04557423 study?
This clinical trial studies the following conditions: Uterine Cervical Neoplasms.
What interventions are being tested in trial NCT04557423?
The interventions under investigation include: Community-Based Education (BEHAVIORAL), Navigation to Screening (BEHAVIORAL), HPV Self-Sampling (BEHAVIORAL).
Who is sponsoring clinical trial NCT04557423?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04557423 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Cervical Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04557423's enrollment target sits among peer trials
797 4th of 8 higher than 5 of 8 other Uterine Cervical Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Uterine Cervical Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women
RECRUITING · NA
-
Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients
COMPLETED · NA
-
Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens
COMPLETED · NA
-
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
RECRUITING · Phase 1
-
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
ACTIVE NOT RECRUITING
-
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06051058 · 798 participants · NA
Care Transitions App for Patients With Multiple Chronic Conditions
- NCT05150691 · 796 participants · Phase 1
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- NCT06208150 · 795 participants · Phase 3
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
- NCT06724172 · 795 participants · NA
CHIME: Comparing Health Interventions for Maternal Equity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI